Board certified hematologist and medical oncologist specializing in plasma cell disorders (MGUS, SMM and multiple myeloma), Myeloma Service, MSKCC
Dr. Shah is a clinical and translational investigator, focusing her research on modifiable risk factors in myeloma development and progression. She also leads nutrition research efforts in plasma cell disorders at MSK and is a pioneer in interventional nutritional trials in this disorder. Her research evaluates the link between nutrition and myeloma via the microbiome, immune and epigenetic mechanisms.
years treating myeloma: 3
Number of Myeloma Patients Treated Annually: 300
Details & contact info
York Avenue Manhattan
New York City, NY, United States, 10128
Send a message to Urvi Shah, MD